Regulation of Bone mass in Myostatin Deficient Mice
Regulation of Bone mass in Myostatin Deficient Mice
批准号:
6314913
负责人:
MARK W HAMRICK
金额:
$14.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-11 至 2003-03-31
中文摘要
描述(来自申请者的逐字):
拟议的学术研究促进奖是为了调查
使用一种新的小鼠模型研究肌肉力量对骨量的影响。具体地说,这项研究
评估关于增加的影响的多个工作假设
活动度水平的肌肉质量,骨的横截面几何形状,骨量,
矿物质含量和显微结构。这些假设是通过比较来检验的
小鼠之间的运动活动、生长激素水平和骨结构
生长和分化因子-8(Myostatin)缺乏和野生型
控制。肌肉生长抑制素对骨骼肌生长的负性调节作用
而肌肉生长抑制素基因缺失的小鼠的肌肉纤维大小和数量增加了一倍
与正常小鼠相比。导致疾病发生的主要因素
骨质疏松症就是骨质流失。一种预防和治疗方法
将生命中骨质流失的潜在灾难性影响降至最低是
通过增加肌肉力量来增加峰值骨量。拟议的研究,由
严格评估肌肉质量增加对骨强度的影响
在出生后的生长过程中,将在我们目前的基础上显著扩大
对生成和维护的重要机制的理解
健康的成人骨骼结构。这项增强奖还将吸引
来自肯特州立大学两个项目的本科生,麦克奈尔
学者和俄亥俄州董事会明星计划,指导骨生物学
研究。因此,拟议项目将提供新的培训。
为来自传统上代表性不足的人群的学生提供机会
生物医学研究界。
英文摘要
DESCRIPTION (Verbatim from the Applicant): The primary objective of the
proposed Academic Research Enhancement Award is to investigate the influence of
muscle strength on bone mass using a new mouse model. Specifically, this study
evaluates multiple working hypotheses concerning the effects of increased
muscle mass on activity level, bone cross-sectional geometry, bone mass,
mineral content, and microstructure. These hypotheses are tested by comparing
locomotor activity, growth hormone levels, and bone structure between mice
deficient in growth and differentiation factor-8 (myostatin) and wild-type
controls. Myostatin functions as a negative regulator of skeletal muscle growth
and myostatin null mice show a doubling of muscle fiber size and number
compared to normal mice. The primary factor leading to the onset of
osteoporosis is bone loss. One preventative and therapeutic approach for
minimizing the potentially disastrous affects of bone loss during life is to
increase peak bone mass by increasing muscle strength. The proposed study, by
critically evaluating the effects of increased muscle mass on bone strength
during postnatal growth, will expand significantly upon our current
understanding of the mechanisms important for generating and maintaining
healthy bone structure in adults. This enhancement award will also engage
undergraduate students from two programs at Kent State University, the McNair
Scholars and Ohio Board of Regents STARS programs, in mentored bone biology
research. The proposed project will therefore provide new training
opportunities for students from populations traditionally underrepresented in
the biomedical research community.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Increased osteogenic response to exercise in metaphyseal versus diaphyseal cortical bone.
与干骺端皮质骨相比,干骺端对运动的成骨反应增加。
DOI:
--
发表时间:
2006
期刊:
Journal of musculoskeletal & neuronal interactions
影响因子:
1.9
作者:
[Hamrick,MW, Skedros,JG, Pennington,C, McNeil,PL]
通讯作者:
McNeil,PL
Novel mechanisms of muscle and bone loss with HIV infection, antiretroviral therapy, and aging.
-
批准号:10696502
-
项目类别:
-
资助金额:$64.04万
-
财政年份:2023
-
负责人:MARK W HAMRICK
-
依托单位:
Effects of Myostatin Deficiency on Bone Strength
-
批准号:6929230
-
项目类别:
-
资助金额:$22.77万
-
财政年份:2004
-
负责人:MARK W HAMRICK
-
依托单位:
Effects of Myostatin Deficiency on Bone Strength
-
批准号:6827153
-
项目类别:
-
资助金额:$22.77万
-
财政年份:2004
-
负责人:MARK W HAMRICK
-
依托单位:
Effects of Myostatin Deficiency on Bone Strength
-
批准号:7084522
-
项目类别:
-
资助金额:$22.24万
-
财政年份:2004
-
负责人:MARK W HAMRICK
-
依托单位:
Effects of Myostatin Deficiency on Bone Strength
-
批准号:7228603
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2004
-
负责人:MARK W HAMRICK
-
依托单位:
Core B - Bone Biology Core
-
批准号:9902283
-
项目类别:
-
资助金额:$29.07万
-
财政年份:--
-
负责人:MARK W HAMRICK
-
依托单位:
Project 2 - Role of bone-derived exosomes in musculoskeletal aging
-
批准号:9902286
-
项目类别:
-
资助金额:$32.91万
-
财政年份:--
-
负责人:MARK W HAMRICK
-
依托单位:
Core B - Bone Biology Core
-
批准号:9209553
-
项目类别:
-
资助金额:$30.4万
-
财政年份:--
-
负责人:MARK W HAMRICK
-
依托单位:
Project 2 - Role of bone-derived exosomes in musculoskeletal aging
-
批准号:9209556
-
项目类别:
-
资助金额:$34.2万
-
财政年份:--
-
负责人:MARK W HAMRICK
-
依托单位:
BONE BIOLOGY CORE
-
批准号:8093265
-
项目类别:
-
资助金额:$15.88万
-
财政年份:--
-
负责人:MARK W HAMRICK
-
依托单位:
THE LEPTIN-IGF1 AXIS IN MUSCULOSKELETAL AGING
-
批准号:8093268
-
项目类别:
-
资助金额:$21.16万
-
财政年份:--
-
负责人:MARK W HAMRICK
-
依托单位:
海外基金